Caribou Biosciences, Inc. Research And Development Expense

Quick Answer

Caribou Biosciences, Inc. reported Research And Development Expense of $109.44 million for the year ending 2025.

  • Caribou Biosciences, Inc. showed a decrease of -15.9% in Research And Development Expense from 2024 to 2025.
  • This data is from Caribou Biosciences, Inc.'s annual report (Form 10-K), filed with the SEC on March 5, 2026.
  • XBRL data for this metric is available from 2019 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 7 years of available data (2019 to 2025), Caribou Biosciences, Inc.'s Research And Development Expense has grown by 363.0%.
  • Historical annual values: Fiscal year 2025: $109.44 million | Fiscal year 2024: $130.15 million | Fiscal year 2023: $112.08 million | Fiscal year 2022: $82.23 million | Fiscal year 2021: $52.26 million | Fiscal year 2020: $34.43 million | Fiscal year 2019: $23.64 million.
  • Data sourced from SEC EDGAR public filings as of June 22, 2026.

Last verified: